D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ABEO holding history
Abeona Therapeutics Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABEO overviewAll 13F holders of ABEOFull Q2 2026 holdings
- Shares (Q2 2026)
- 57,100
- Value
- $352.9K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 57,100 | $352.9K | <0.1% | −43,965−43.5% | Reduced | Holders |
| Q1 2026 | 101,065 | $452.8K | <0.1% | −4,900−4.6% | Reduced | Holders |
| Q4 2025 | 105,965 | $558.4K | <0.1% | −20,419−16.2% | Reduced | Holders |
| Q3 2025 | 126,384 | $667.3K | <0.1% | +126,384 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −49,220−100.0% | Sold outConverted for a 1-for-25 split | Holders |
| Q2 2022 | 1,230,507 | $256.0K | <0.1% | −803,644−39.5% | Reduced | Holders |
| Q1 2022 | 2,034,151 | $641.0K | <0.1% | −484,504−19.2% | Reduced | Holders |
| Q4 2021 | 2,518,655 | $849.0K | <0.1% | +2,518,655 | New | Holders |